Skip to main content

Table 1 Demographic and clinical profile of 122 NSCLC patients

From: Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers

Variable

cases (%)

Age (mean ± s.d.*)

65.1 ± 10.2

Gender

 

   Male

52 (42.6)

   Female

70 (57.4)

Smoking status

 

   Smoking

81 (66.4)

   Never-smoking

41 (33.6)

Tumor types

 

   Adenocarcinoma

72 (59.0)

   Squamous cell carcinoma

22 (18.0)

   Bronchioloalveolar carcinoma

15 (12.3)

   Adenosquamous carcinoma

9 (7.4)

   Large cell carcinoma

2 (1.6)

   Carcinoid

1 (0.8)

   Neuroendocrine

1 (0.8)

Tumor stage

 

   I

54 (44.3)

   II

24 (19.7)

   III

19 (15.6)

   IV

11 (9.0)

   Unknown

14 (11.5)

  1. *: standard deviation